Volunteer Andrew Matzen receives a trial Ebola vaccine at the Centre for Clinical Vaccinology and Tropical Medicine in Oxford, southern England January 16, 2015. Johnson & Johnson said that newly formed groups supporting work on its experimental Ebola vaccine would receive 100 million euros ($115 million) from Europe's Innovative Medicines Initiative to speed development. Photograph taken January 16, 2015. REUTERS/Eddie Keogh (BRITAIN - Tags: SCIENCE TECHNOLOGY HEALTH)